Zinc transporter 8 autoantibody (ZnT8A) by ELISA for diagnosing type 1 diabetes among Chinese people
- 26 Downloads
This study aimed to evaluate the utility of enzyme-linked immunosorbent assay (ELISA) to measure ZnT8A for diagnosing type 1 diabetes among Chinese people. We recruited a group of 95 patients with type 1 diabetes, 130 patients with type 2 diabetes, and 110 subjects without diabetes. We measured ZnT8A level by ELISA and glutamic acid decarboxylase antibody (GADA) level by radioimmunoassay. We collected data on their history-based variables, body mass index (BMI), fasting blood glucose, glycosylated hemoglobin, and lipid levels. 24.2% were positive for ZnT8A in type 1 diabetics, compared to 0.0% in type 2 diabetics and 0.9% in the participants without diabetes (both p < 0.001). And the type 1 diabetics had higher ZnT8A level compared with the latter two groups (both p < 0.001). The frequency of ZnT8A in the “classical” type 1 diabetics was higher than that in patients with latent autoimmune diabetes in adults (45.0 vs. 18.7%, p < 0.05). The frequency/level of ZnT8A was higher in the youngest group (all p < 0.05). The ROC curve area was 0.892. The combination of ZnT8A and GADA increased the diagnostic sensitivity. The ZnT8A level was correlated with the GADA level. ZnT8A-positive type 1 diabetics had younger age at diagnosis (p = 0.022), lower BMI scores (p = 0.016), and more frequent ketosis (p = 0.034) and needed more insulin (p = 0.041) than ZnT8A-negative type 1 diabetics. This study demonstrated the value of ZnT8A in addition to GADA for the diagnosis of type 1 diabetes.
KeywordsZinc transporter 8 autoantibody Enzyme-linked immunosorbent assay Glutamic acid decarboxylase antibody Type 1 diabetes mellitus Chinese
We thank all of the participants who made this study possible.
Xuan Qiu: literature search, design, clinical studies, statistical analysis, manuscript preparation; Cuili Ning: clinical studies, data acquisition, manuscript editing; Lin Xiao: data analysis, manuscript editing; Zhenyun Mu: data analysis, statistical analysis, manuscript editing; Kuanzhi Liu: concepts, design, definition of intellectual content, manuscript review. All authors have read and contributed to the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 6.Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S5–20.Google Scholar
- 7.Chinese Medical Association Diabetes Branch. Chinese guidelines for diagnosis and treatment of type 1 diabetes. 1st ed. Beijing: People's Medical Publishing House; 2012.Google Scholar
- 9.Kawasaki E, Maruyama T, Imagawa A, Awata T, Ikegami H, Uchigata Y, et al. Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the Committee of Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus. J Diabetes Investig. 2014;5:115–8.CrossRefGoogle Scholar
- 10.Milicic T, Jotic A, Markovic I, Lalic K, Jeremic V, Lukic L, et al. High risk first degree relatives of type 1 diabetics: an association with increases in CXCR3 (+) T memory cells reflecting an enhanced activity of Th1 autoimmune response. Int J Endocrinol. 2014;2014:1–9. https://doi.org/10.1155/2014/589360.CrossRefGoogle Scholar
- 14.Faccinetti NI, Guerra LL, Penas SA, Iacono RF, Frechtel GD, Trifone L, et al. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants. Eur J Endocrinol. 2016;174:157–65.CrossRefGoogle Scholar
- 20.Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di PS, et al. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: non insulin requiring autoimmune diabetes (NIRAD) 4. Diabetes Care. 2010;33:104–8.CrossRefGoogle Scholar
- 22.Juusola M, Parkkola A, Härkönen T, Siljander H, Ilonen J, Åkerblom HK, et al. Positivity for zinc transporter 8 autoantibodies at diagnosis is subsequently associated with reduced β-cell function and higher exogenous insulin requirement in children and adolescents with type 1 diabetes. Diabetes Care. 2016;39:118–21.CrossRefGoogle Scholar
- 29.Buzzetti R, Spoletini M, Zampetti S, Campagna G, Marandola L, Panimolle F, et al. Tyrosine phosphatase-related islet antigen 2 (256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes. Diabetes Care. 2015;38:513–20.CrossRefGoogle Scholar